Tilray (TLRY) earnings: expect $22 million revenue

6:45 pm ET, 08 May 2019

Tilray (TLRY) is announcing earnings on May 14 after the market closes. We combed through analyst estimates to understand what the company revenue and earnings are predicted to look like.

What should you expect from the upcoming earnings?

Revenue for the next quarter is expected to be $22M.

Earnings per share are expected to come in at $-0.28.

How did the stock do last month?

Over the last month, Tilray (TLRY) returned -20.76%.

How is the stock valued?

Tilray (TLRY) forward P/E ratio is 1255.75, and it’s high compared to its industry peers’ P/E ratios.

What do analysts say about the stock?

Tilray (TLRY) average analyst price target is 114.17% above its current price ($46.29).

For the latest price and information on Tilray, please visit Finstead and ask for "TLRY", "TLRY analysis" or "TLRY news".

Tilray (TLRY): will it ride high prior to October 17?

12:14 pm ET, 03 Oct 2018

Tilray (TLRY) shares are trading at $149.00, up 11%.  The company has declined 30% from its peak of $214, but it still generates a lot of interest in the trader community.  What's driving TLRY stock price? What's TLRY stock price forecast?

Tilray is engaged in the sale and development of medical cannabis. The company currently derives most of its revenue from Canada and it is actively looking to grow globally. The stock has been very volatile - traders love the stock.

Tilray priced its shares at $17 raising $153 million in July this year. It is a dual class structure with Class 2 shareholders, where IPO investors will have one vote per share, and Class 1 shareholders will have three votes for one share.

The stock has yielded a return of 542% since Tilray got listed on the exchange earlier this year.  Since recreational marijuana will be legal in Canada starting October 17, we are likely to see a lot of movement with this stock.

What's the long-term potential for Tilray? It's treating all diseases that previously haven't been addressed with medical cannabis.  Tilray recently announced that it exported medical cannabis from Canada to Australia to treat critically ill children.

What is the sentiment towards the TLRY stock? Our technical analysis shows that:

  • The stock short-term sentiment (next 30 days) is trending positive;
  • The mid-term sentiment (3-6 months) is positive;
  • The long-term sentiment (9-12 months) is neutral. 

Over the last month, Tilray (TLRY) returned +207.96%.

Tilray (TLRY) average analyst price target ($52.00) is -57.72% below its current price ($123.00).

For the latest price and information on Tilray, please visit Finstead and search for "TLRY price" or "TLRY news".

Tilray (TLRY) stock: is it overbought?

4:43 pm ET, 12 Sep 2018


Tilray (TLRY) shares are trading at 109.60, up 14%. What's driving TLRY stock price? What's TLRY stock price forecast, and what should investors know about Tilray?

Tilray engages in research, cultivation, processing, and distribution of medical cannabis globally. It is the best performing US IPO for 2018 with a return of 277%. The stock has been the darling of the stock market as investors prepare for the beginning of recreational cannabis legal distribution in Canada.

The U.S. House panel is also expected to vote on a bill to expand research opportunities for marijuana.  The bulls say that the company will be a major player in the Canadian Cannabis recreational market. But the bears worry about the high valuation of the company.

The company’s second-quarter revenue rose 95% to $9.7 million with a net loss of $12.8 million compared to $2.4 million for the same quarter in 2017. The company’s products are now available in 11 countries and it is actively looking to expand its global reach.

What is the sentiment towards the TLRY stock? Our technical analysis shows that:

  • The stock short-term sentiment (next 30 days) is trending positive;
  • The mid-term sentiment (3-6 months) is neutral;
  • The long-term sentiment (9-12 months) is neutral. 

Over the last month, Tilray (TLRY) returned +272.09%.

Tilray (TLRY) average analyst price target ($52.00) is -42.13% below its current price ($89.86).

For the latest price and information on Tilray, please visit Finstead and search for "TLRY price" or "TLRY news".

Tilray (TLRY) Stock Guide

Updated at: 7:12 pm ET, 23 Sep 2020

Before we start: if you're looking for TLRY stock price, you can quickly find it out by visiting Finny and typing "TLRY quote". If you're looking for a quick scoop on TLRY stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "TLRY". You'll get all this info in one place. Or you can just type "TLRY news" to get the latest stock news.

Looking to buy or sell Tilray (TLRY)? Interested in getting the full scoop on TLRY, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this TLRY stock guide, we'll address key questions about TLRY, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are TLRY earnings?
2. TLRY buy or sell? What is TLRY Finny Score?
3. What are the reasons to buy TLRY? Why should I buy TLRY stock?
4. What are the reasons to sell TLRY? Why should I sell TLRY stock?
5. What are TLRY key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are TLRY earnings?

TLRY trailing 12-month earnings per share (EPS) is -$4.73.

Analysis

2. TLRY buy or sell? What is TLRY Finny Score?

#{finnyScore:60}Our quantitative analysis shows 3 reasons to buy and 2 reasons to sell TLRY, resulting in Finny Score of 60.

3. What are the reasons to buy TLRY? Why should I buy TLRY stock?

Here are the reasons to buy TLRY stock:

  • TLRY quarterly revenue growth was 10.10%, higher than the industry and sector average revenue growth (0.17% and 0.83%, respectively). See TLRY revenue growth chart.
  • TLRY PEG ratio (P/E adjusted for growth) is 0.59, which is low compared to its industry peers’ PEG ratios. See TLRY PEG chart.
  • TLRY cash to debt ratio is 0.30, higher than the average industry (0.13) and sector (0.16) cash to debt ratio. See TLRY cash to debt chart.

4. What are the reasons to sell TLRY? Why should I sell TLRY stock?

Let's look at the reasons to sell TLRY stock (i.e., the bear case):

  • TLRY short share of float is 21.52%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See TLRY short share of float chart.
  • TLRY short interest (days to cover the shorts) ratio is 3.19. The stock garners more short interest than the average industry, sector or S&P 500 stock. See TLRY short interest ratio chart.

Key Stats

5. What are TLRY key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for TLRY:

Metrics TLRY
Price $6.46
Average Price Target / Upside $8.00 / 23.84%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Number of Employees 330
Market Cap $759.58M
Forward P/E Ratio -9.35
Price/Book Ratio 4.13
Revenue (TTM) $184.08M
YoY Quarterly Revenue Growth 10.10%
Profit Margin -283.20%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us